Ohio Public Employees Retirement System (OPERS)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-129,791
Closed -$23.8M 2025
2021
Q2
$23.8M Buy
129,791
+12,953
+11% +$2.38M 0.08% 220
2021
Q1
$17.9M Buy
116,838
+8,443
+8% +$1.29M 0.07% 243
2020
Q4
$16.9M Buy
108,395
+22,825
+27% +$3.57M 0.08% 229
2020
Q3
$9.79M Buy
85,570
+3,416
+4% +$391K 0.05% 293
2020
Q2
$9.22M Sell
82,154
-34,992
-30% -$3.93M 0.05% 312
2020
Q1
$10.5M Sell
117,146
-8,479
-7% -$761K 0.07% 244
2019
Q4
$13.6M Sell
125,625
-2,890
-2% -$313K 0.07% 250
2019
Q3
$12.6M Buy
128,515
+564
+0.4% +$55.2K 0.07% 276
2019
Q2
$16.8M Sell
127,951
-7,234
-5% -$948K 0.09% 225
2019
Q1
$18.3M Buy
135,185
+558
+0.4% +$75.4K 0.1% 213
2018
Q4
$13.1M Sell
134,627
-6,519
-5% -$635K 0.08% 242
2018
Q3
$19.6M Sell
141,146
-2,115
-1% -$294K 0.1% 211
2018
Q2
$17.8M Sell
143,261
-1,725
-1% -$214K 0.09% 229
2018
Q1
$16.2M Sell
144,986
-8,960
-6% -$999K 0.08% 240
2017
Q4
$18.4M Buy
153,946
+2,676
+2% +$320K 0.09% 229
2017
Q3
$21.2M Buy
151,270
+107
+0.1% +$15K 0.11% 206
2017
Q2
$18.4M Buy
151,163
+2,394
+2% +$291K 0.1% 221
2017
Q1
$18M Buy
148,769
+242
+0.2% +$29.3K 0.1% 226
2016
Q4
$19.4M Buy
148,527
+249
+0.2% +$32.6K 0.11% 209
2016
Q3
$18.2M Buy
148,278
+188
+0.1% +$23K 0.11% 206
2016
Q2
$17.3M Sell
148,090
-511
-0.3% -$59.7K 0.11% 211
2016
Q1
$20.7M Sell
148,601
-8,385
-5% -$1.17M 0.14% 171
2015
Q4
$29.9M Sell
156,986
-1,013
-0.6% -$193K 0.18% 124
2015
Q3
$24.7M Buy
157,999
+399
+0.3% +$62.4K 0.16% 152
2015
Q2
$28.5M Buy
157,600
+13,018
+9% +$2.35M 0.16% 148
2015
Q1
$25.1M Buy
144,582
+495
+0.3% +$85.8K 0.14% 169
2014
Q4
$26.7M Sell
144,087
-74
-0.1% -$13.7K 0.16% 151
2014
Q3
$23.9M Sell
144,161
-7,462
-5% -$1.24M 0.14% 164
2014
Q2
$23.7M Buy
151,623
+91,462
+152% +$14.3M 0.13% 174
2014
Q1
$9.15M Sell
60,161
-10,838
-15% -$1.65M 0.05% 361
2013
Q4
$9.45M Buy
70,999
+9,772
+16% +$1.3M 0.05% 386
2013
Q3
$7.11M Buy
61,227
+2,607
+4% +$303K 0.04% 477
2013
Q2
$5.41M Buy
+58,620
New +$5.41M 0.03% 521